Turk Ilac plans to produce 80 million doses of injections as part of the project at Tashkent Pharma Park

Tashkent, Uzbekistan (UzDaily.uz) -Turk Ilac received a certificate of participation in the innovative scientific and production pharmaceutical cluster Tashkent Pharma Park. Director of the Agency for Development of the Pharmaceutical Industry Abdulla Azizov presented a certificate to Turk Ilac, confirming its participation in the cluster. Turk Ilac plans to produce injections (serums) and create more than 200 new jobs as part of a new project in Tashkent Pharma Park. The annual production capacity will be 80 million doses of pharmaceutical injections. The founder of Turk Ilac is Turk Ilac ve Serum Sanayi AS, founded in 2010 by Mehmet Berat Battal. Currently, the pharmaceutical production plant covers an area of 80,000 square meters.

Source UzDaily.uz